title: Hypothesis: central nervous system delivery of cyclosporine A for therapy of progressive multifocal leukoencephalopathy.
authors.forename: Daniele
authors.initials: D
authors.lastname: Focosi
authors.forename: Richard Eric
authors.initials: RE
authors.lastname: Kast
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Maggi
authors.forename: Linda
authors.initials: L
authors.lastname: Vatteroni
authors.forename: Luca
authors.initials: L
authors.lastname: Ceccherini-Nelli
authors.forename: Mario
authors.initials: M
authors.lastname: Petrini
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism; D002339:Carotid Arteries; D016572:Cyclosporine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy*; D051379:Mice; D050778:NFATC Transcription Factors / Q000378:metabolism; D051381:Rats
chemical_list: D007166:Immunosuppressive Agents; D050778:NFATC Transcription Factors; D016572:Cyclosporine